DEBIOPHARM WE DEVELOP FOR PATIENTS
LIVE

Serial Number

79390732

Owner

Après-demain SA

Attorney

Duane M. Byers

Filing Date

Oct 19, 2023

Add to watchlist:

No watchlists yet
View on USPTO

DEBIOPHARM WE DEVELOP FOR PATIENTS Trademark

Serial Number: 79390732 • Registration: 8026419

DEBIOPHARM WE DEVELOP FOR PATIENTS is a trademark filed by Après-demain SA on October 19, 2023. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Après-demain SA (9 trademarks)

Forum après-demain,

Entity Type: 99

Trademark Details

Filing Date

October 19, 2023

Registration Date

November 18, 2025

Published for Opposition

September 30, 2025

Goods & Services

Medical services; Hygienic and beauty care for human beings

Scientific and technological services, namely, scientific research, design, and analysis in the fields of biology, medicine and pharmaceuticals, and research and design relating thereto; industrial analysis, namely, analysis of industrial biopharmaceuticals; industrial research services in the fields of biology, medicine and pharmaceuticals; design and development of computer hardware and software

Outsource service provider in the field of administrative business management

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 18, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 3, 2026 FICS
FINAL DISPOSITION PROCESSED
Jun 3, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 18, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Nov 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Nov 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 28, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 28, 2025 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 22, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 6, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 6, 2025 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 28, 2025 GNFN
FINAL REFUSAL E-MAILED
Feb 28, 2025 GNFR
FINAL REFUSAL WRITTEN
Feb 28, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2024 TROA
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Dec 10, 2024 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jul 27, 2024 LIMG
REFUSAL PROCESSED BY IB
Jul 15, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 24, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 24, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 7, 2024 RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 7, 2024 RFCR
NON-FINAL ACTION WRITTEN
May 23, 2024 CNRT
ASSIGNED TO EXAMINER
May 18, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 7, 2024 REPR